The incidence of postoperative re-stratification for recurrence in well-differentiated thyroid cancer-a retrospective cohort study.

Low risk completion thyroidectomy hemi-thyroidectomy (HT) partial thyroidectomy risk stratification

Journal

Gland surgery
ISSN: 2227-684X
Titre abrégé: Gland Surg
Pays: China (Republic : 1949- )
ID NLM: 101606638

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 21 02 2021
accepted: 22 07 2021
entrez: 16 9 2021
pubmed: 17 9 2021
medline: 17 9 2021
Statut: ppublish

Résumé

After diagnosing well-differentiated thyroid cancer (WDTC), assessment of the risk for disease-specific recurrence is essential for deciding between hemi-thyroidectomy (HT) and total thyroidectomy (TT). The American Thyroid Association (ATA) 2015 guidelines suggest that patients with 1-4 cm WDTC without suspicious features may be suitable for HT. Patients' preoperatively determined risk levels are re-stratified according to surgical and final histopathological findings. The incidence and clinical implications of high-risk features discovered postoperatively in patients with preoperatively determined low-risk WDTC are yet to be better defined. Thyroidectomies performed in the Tel-Aviv Sourasky Medical Center (TASMC) [2006-2018] were included. Patients with 1-4 cm WDTC without evidence of positive cervical lymph nodes, invasion to adjacent structures, or high-risk cytology were considered at low risk for disease-specific recurrence-suitable for lobectomy. Patients were stratified according to their risk for disease-specific recurrence, pre- and postoperatively, and the rate of completion thyroidectomy was determined. In total, 301 (21%) patients were preoperatively stratified as low risk. Forty-six of them (15%) were re-stratified postoperatively as intermediate-to-high-risk. There were no significant differences in the characteristics of the patients who maintained their original stratification to patients who were upscaled to a higher risk level postoperatively. We report a 15% rate of postoperative risk escalation of patients who required completion thyroidectomy according to current ATA guidelines. In our opinion, this rate of postoperative WDTC upscaling of risk requiring more radical surgery than originally planned, is acceptable. Meticulous preoperative personalized evaluation by an experienced multidisciplinary dedicated team is essential.

Sections du résumé

BACKGROUND BACKGROUND
After diagnosing well-differentiated thyroid cancer (WDTC), assessment of the risk for disease-specific recurrence is essential for deciding between hemi-thyroidectomy (HT) and total thyroidectomy (TT). The American Thyroid Association (ATA) 2015 guidelines suggest that patients with 1-4 cm WDTC without suspicious features may be suitable for HT. Patients' preoperatively determined risk levels are re-stratified according to surgical and final histopathological findings. The incidence and clinical implications of high-risk features discovered postoperatively in patients with preoperatively determined low-risk WDTC are yet to be better defined.
METHODS METHODS
Thyroidectomies performed in the Tel-Aviv Sourasky Medical Center (TASMC) [2006-2018] were included. Patients with 1-4 cm WDTC without evidence of positive cervical lymph nodes, invasion to adjacent structures, or high-risk cytology were considered at low risk for disease-specific recurrence-suitable for lobectomy. Patients were stratified according to their risk for disease-specific recurrence, pre- and postoperatively, and the rate of completion thyroidectomy was determined.
RESULTS RESULTS
In total, 301 (21%) patients were preoperatively stratified as low risk. Forty-six of them (15%) were re-stratified postoperatively as intermediate-to-high-risk. There were no significant differences in the characteristics of the patients who maintained their original stratification to patients who were upscaled to a higher risk level postoperatively.
CONCLUSIONS CONCLUSIONS
We report a 15% rate of postoperative risk escalation of patients who required completion thyroidectomy according to current ATA guidelines. In our opinion, this rate of postoperative WDTC upscaling of risk requiring more radical surgery than originally planned, is acceptable. Meticulous preoperative personalized evaluation by an experienced multidisciplinary dedicated team is essential.

Identifiants

pubmed: 34527547
doi: 10.21037/gs-21-105
pii: gs-10-08-2354
pmc: PMC8411091
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2354-2367

Informations de copyright

2021 Gland Surgery. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://dx.doi.org/10.21037/gs-21-105). The authors have no conflicts of interest to declare.

Références

Surgery. 2018 May;163(5):1134-1143
pubmed: 29426618
Thyroid. 2012 Nov;22(11):1144-52
pubmed: 23083442
Surgery. 2009 Oct;146(4):554-8; discussion 558-60
pubmed: 19789012
Head Neck. 2011 May;33(5):645-9
pubmed: 20687168
Cancer. 2017 Feb 1;123(3):372-381
pubmed: 27741354
Clin Endocrinol (Oxf). 2017 Feb;86(2):236-242
pubmed: 27467318
Surgery. 2020 Jan;167(1):10-17
pubmed: 31515125
Thyroid. 2016 Jun;26(6):820-4
pubmed: 27083216
Am J Surg. 1992 Dec;164(6):658-61
pubmed: 1463119
Ann Surg Oncol. 2005 Jan;12(1):81-9
pubmed: 15827782
Bosn J Basic Med Sci. 2017 May 20;17(2):144-151
pubmed: 28284178
Int J Surg. 2019 Dec;72:156-165
pubmed: 31704426
CA Cancer J Clin. 2017 Mar;67(2):93-99
pubmed: 28094848
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
Cancers (Basel). 2018 Dec 27;11(1):
pubmed: 30591680
J Clin Endocrinol Metab. 2001 Apr;86(4):1447-63
pubmed: 11297567
Am Surg. 2009 Jan;75(1):20-4
pubmed: 19213391
Eur Thyroid J. 2020 Feb;9(2):73-84
pubmed: 32257956
Ann Surg. 2014 Oct;260(4):601-5; discussion 605-7
pubmed: 25203876
Medicine (Baltimore). 2017 Jul;96(27):e7461
pubmed: 28682915
Arch Otolaryngol Head Neck Surg. 2010 Nov;136(11):1055-61
pubmed: 21079156
J Am Coll Surg. 2010 Jun;210(6):895-900
pubmed: 20510797
Thyroid. 2009 Nov;19(11):1167-214
pubmed: 19860577
Ann Surg. 2007 Sep;246(3):375-81; discussion 381-4
pubmed: 17717441
Head Neck. 2018 Jun;40(6):1214-1218
pubmed: 29417654
J Thyroid Res. 2016;2016:4127278
pubmed: 27403370
ORL J Otorhinolaryngol Relat Spec. 2013;75(1):6-17
pubmed: 23486083
Otolaryngol Head Neck Surg. 2011 Feb;144(2):210-5
pubmed: 21493418
J Clin Endocrinol Metab. 2019 Mar 15;:
pubmed: 30874735
Surgery. 1998 Dec;124(6):958-64; discussion 964-6
pubmed: 9854569
Surgery. 2012 Apr;151(4):571-9
pubmed: 22001636
Surgery. 1988 Dec;104(6):954-62
pubmed: 3194847

Auteurs

Narin N Carmel Neiderman (NN)

Department of Otolaryngology, Head and Neck, Maxillofacial Surgery, Tel-Aviv Sourasky Medical Center, Affiliated to the Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Irit Duek (I)

Department of Otolaryngology, Head and Neck, Maxillofacial Surgery, Tel-Aviv Sourasky Medical Center, Affiliated to the Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Adi Ravia (A)

Department of Otolaryngology, Head and Neck, Maxillofacial Surgery, Tel-Aviv Sourasky Medical Center, Affiliated to the Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Ronel Yaka (R)

Department of Otolaryngology, Head and Neck, Maxillofacial Surgery, Tel-Aviv Sourasky Medical Center, Affiliated to the Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Anton Warshavsky (A)

Department of Otolaryngology, Head and Neck, Maxillofacial Surgery, Tel-Aviv Sourasky Medical Center, Affiliated to the Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Barak Ringel (B)

Department of Otolaryngology, Head and Neck, Maxillofacial Surgery, Tel-Aviv Sourasky Medical Center, Affiliated to the Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Nidal Muhanna (N)

Department of Otolaryngology, Head and Neck, Maxillofacial Surgery, Tel-Aviv Sourasky Medical Center, Affiliated to the Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Gilad Horowitz (G)

Department of Otolaryngology, Head and Neck, Maxillofacial Surgery, Tel-Aviv Sourasky Medical Center, Affiliated to the Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Tomer Ziv Baran (T)

School of Public Health, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Dan M Fliss (DM)

Department of Otolaryngology, Head and Neck, Maxillofacial Surgery, Tel-Aviv Sourasky Medical Center, Affiliated to the Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Classifications MeSH